Royal Bank Of Canada Centogene N.V. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.65 - $1.25 $89 - $171	137 New	137 $0
Q3 2023 Nov 14, 2023	BUY	$1.0 - $1.64 $50 - $82	50 New	50 $0
Q1 2023 May 15, 2023	SELL	$0.65 - $1.43 $1 - $2	-2 Reduced 3.23%	60 $0
Q4 2022 Feb 14, 2023	SELL	$0.72 - $1.28 $42 - $75	-59 Reduced 48.76%	62 $0
Q1 2022 May 16, 2022	SELL	$3.3 - $5.44 $283 - $467	-86 Reduced 41.55%	121 $1,000
Q4 2021 Feb 14, 2022	BUY	$4.56 - $10.56 $506 - $1,172	111 Added 115.63%	207 $1,000
Q3 2021 Nov 15, 2021	SELL	$9.9 - $11.72 $13,454 - $15,927	-1,359 Reduced 93.4%	96 $1,000
Q2 2021 Aug 16, 2021	BUY	$9.02 - $12.93 $13,124 - $18,813	1,455 New	1,455 $15,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.